On Thursday before the open, Celgene Corporation (NASDAQ:CELG) reported its fourth-quarter earnings results. The company beat on earnings per share and revenue expectations. It also provided good, but not great guidance (more on …
A number of biotech firms that have real long-term growth have for some reason, cheaper share prices than you’d expect, and Celgene Corporation (NASDAQ:CELG) could be one of the biggest bargains of all. After reporting less than …
Celgene turned in a brutal third-quarter earnings report, missing revenue forecasts and cutting its long-term profit outlook. Traders were woefully unhedged by several measures, leaving them vulnerable to feel the brunt of the stock's 20% drop. …
Sirius’ stock price was $7.22 at the trading day’s close yesterday ... Lingering outside the spotlight of the top 10 most shorted Nasdaq stocks again in the most …
Even some of the biggest and best have things go wrong every now and then. Celgene (NASDAQ: CELG) has been the best-performing biotech stock over the last five years among big biotechs with market caps over $50 billion. And now, …
Even some of the biggest and best have things go wrong every now and then. Celgene (NASDAQ: CELG) has been the best-performing biotech stock over the last five years among big biotechs with market caps over $50 billion. And now, …
When investors are looking for high growth and reasonable valuations in the biotech space, Celgene Corporation (NASDAQ:CELG) is one of the first companies to come to mind. However, October was not kind to the CELG stock …
On Thursday before the open, Celgene Corporation (NASDAQ:CELG) reported its fourth-quarter earnings results. The company beat on earnings per share and revenue expectations. It also provided good, but not great guidance (more on …